Drug intelligence / Profile preview

2-(4-hydroxy-phenyl)benzofuran-5-ol

Development stage: Unknown
Modality: Small Molecules

Overview

2-(4-hydroxy-phenyl)benzofuran-5-ol is a synthetic small molecule belonging to the class of 2-arylbenzofuran flavonoids. It has been studied as an experimental compound and functions primarily as an inhibitor of estrogen receptor beta and estrogen receptor. The compound is not approved for clinical use in any country and has not advanced beyond preclinical or early investigational stages. Its mechanism involves binding to estrogen receptors, potentially modulating pathways such as the estrogen signaling pathway and prolactin signaling pathway[1][7]. No marketed formulations or brand names are associated with this molecule.

Other names: 2-(4-hydroxyphenyl)-1-benzofuran-5-ol2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL

Targets

ESR2 (ERβ)

Beyond the preview

Go deeper on 2-(4-hydroxy-phenyl)benzofuran-5-ol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(4-hydroxy-phenyl)benzofuran-5-ol.

Explore the full profile